Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9Y44
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,280
Award facts
- Contract value 100% obligated
- $28,279.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,279.80 delivery order to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 16, 2026, for the supply of Dupixent 300 mg/2 mL pens, with an ultimate completion date of January 20, 2026. The contract utilizes firm fixed-price pricing and was not designated as a set-aside award, indicating it was competitively awarded. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania and now operating under parent company Cencora, Inc., maintains a significant role in the federal medical supply chain through its prime vendor agreements with the Defense Logistics Agency. The company's contracts encompass a broad portfolio of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies supporting military treatment facilities and veterans' healthcare systems worldwide. Dupixent is a biologic medication commonly used for treating moderate-to-severe eczema, asthma, and other allergic conditions, making this procurement consistent with the Defense Health Agency's critical medical commodity needs.
Quick answers
Who was awarded contract SPE2DR26F9Y44?
SPE2DR26F9Y44 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9Y44 worth?
The government has obligated $28,280 on SPE2DR26F9Y44.
Is contract SPE2DR26F9Y44 an order under another contract?
Yes. SPE2DR26F9Y44 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9Y44 competed?
The extent of competition for SPE2DR26F9Y44 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award